1-3 of 3
Raphael C Bosse, BS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Chemosensitizing Leukemia By Targeting the Leukemia Microenvironment with Vascular Disrupting Combretastatins

Raphael C Bosse, BS, Briana Wasserstrom, Elizabeth Wise, BS, Amy Meacham, MS, Christopher R. Cogle, MD
Journal: Blood
Blood (2014) 124 (21): 2315.
https://doi.org/10.1182/blood.V124.21.2315.2315
Published: 2014
Journal Articles

A Phase I Study Of The Vascular Disrupting Combretastatin, OXi4503, In Patients With Relapsed and Refractory Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS)

Daniel Turner, BS, Andres Gonzalez, BS, Leslie Pettiford, RN, Amy Meacham, MS, Elizabeth Wise, BS, Raphael C Bosse, BS, Dai Chaplin, PhD, Jack W. Hsu, MD, Randy A Brown, MD, John W Hiemenz, MD, Maxim Norkin, MD, PhD, John R Wingard, MD, Christopher R Cogle, MD
Journal: Blood
Blood (2013) 122 (21): 1463.
https://doi.org/10.1182/blood.V122.21.1463.1463
Published: 2013
Journal Articles

Vascular Disrupting Combretastatins Impair Bone Marrow Endothelial Cells by Depolymerizing the Microtubule Cytoskeleton.

Raphael C Bosse, BS, Sunil Rohatgi, BS, Amy Meacham, MS, Elizabeth Wise, BS, Edward W Scott, PhD, Christopher R Cogle, MD
Journal: Blood
Blood (2012) 120 (21): 2183.
https://doi.org/10.1182/blood.V120.21.2183.2183
Published: 2012